Logo image of BRZE

BRAZE INC-A (BRZE) Stock Fundamental Analysis

NASDAQ:BRZE - Nasdaq - US10576N1028 - Common Stock

45.09  +0.98 (+2.22%)

Premarket: 44.51 -0.58 (-1.29%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BRZE. BRZE was compared to 285 industry peers in the Software industry. While BRZE has a great health rating, there are worries on its profitability. BRZE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BRZE was profitable.
In the past year BRZE had a positive cash flow from operations.
In the past 5 years BRZE always reported negative net income.
In the past 5 years BRZE reported 4 times negative operating cash flow.
BRZE Yearly Net Income VS EBIT VS OCF VS FCFBRZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

BRZE has a worse Return On Assets (-13.64%) than 65.95% of its industry peers.
BRZE has a Return On Equity (-25.07%) which is in line with its industry peers.
Industry RankSector Rank
ROA -13.64%
ROE -25.07%
ROIC N/A
ROA(3y)-15.71%
ROA(5y)-17.29%
ROE(3y)-25.19%
ROE(5y)-32.07%
ROIC(3y)N/A
ROIC(5y)N/A
BRZE Yearly ROA, ROE, ROICBRZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

BRZE's Gross Margin of 68.64% is in line compared to the rest of the industry. BRZE outperforms 51.97% of its industry peers.
In the last couple of years the Gross Margin of BRZE has grown nicely.
BRZE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.56%
GM growth 5YN/A
BRZE Yearly Profit, Operating, Gross MarginsBRZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

7

2. Health

2.1 Basic Checks

BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BRZE has been increased compared to 1 year ago.
There is no outstanding debt for BRZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BRZE Yearly Shares OutstandingBRZE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BRZE Yearly Total Debt VS Total AssetsBRZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 6.93 indicates that BRZE is not in any danger for bankruptcy at the moment.
The Altman-Z score of BRZE (6.93) is better than 71.68% of its industry peers.
BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.93
ROIC/WACCN/A
WACC11.19%
BRZE Yearly LT Debt VS Equity VS FCFBRZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 1.99 indicates that BRZE should not have too much problems paying its short term obligations.
BRZE has a Current ratio (1.99) which is in line with its industry peers.
BRZE has a Quick Ratio of 1.99. This is a normal value and indicates that BRZE is financially healthy and should not expect problems in meeting its short term obligations.
BRZE has a Quick ratio of 1.99. This is in the better half of the industry: BRZE outperforms 60.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
BRZE Yearly Current Assets VS Current LiabilitesBRZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

BRZE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.56%, which is quite impressive.
BRZE shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.30%.
The Revenue has been growing by 46.45% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)105.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)28.3%
Revenue growth 3Y46.45%
Revenue growth 5YN/A
Sales Q2Q%22.66%

3.2 Future

Based on estimates for the next years, BRZE will show a very strong growth in Earnings Per Share. The EPS will grow by 61.01% on average per year.
Based on estimates for the next years, BRZE will show a very strong growth in Revenue. The Revenue will grow by 20.14% on average per year.
EPS Next Y143.4%
EPS Next 2Y77.15%
EPS Next 3Y61.01%
EPS Next 5YN/A
Revenue Next Year26.43%
Revenue Next 2Y21.6%
Revenue Next 3Y20.14%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BRZE Yearly Revenue VS EstimatesBRZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
BRZE Yearly EPS VS EstimatesBRZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2254.50 indicates a quite expensive valuation of BRZE.
BRZE's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 28.29. BRZE is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 152.35, the valuation of BRZE can be described as expensive.
BRZE's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BRZE is more expensive than 60.22% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.44, BRZE is valued quite expensively.
Industry RankSector Rank
PE 2254.5
Fwd PE 152.35
BRZE Price Earnings VS Forward Price EarningsBRZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 500 1K 1.5K 2K

4.2 Price Multiples

BRZE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 5254.41
EV/EBITDA N/A
BRZE Per share dataBRZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as BRZE's earnings are expected to grow with 61.01% in the coming years.
PEG (NY)15.72
PEG (5Y)N/A
EPS Next 2Y77.15%
EPS Next 3Y61.01%

More info and screens

0

5. Dividend

5.1 Amount

BRZE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRAZE INC-A

NASDAQ:BRZE (1/21/2025, 8:00:00 PM)

Premarket: 44.51 -0.58 (-1.29%)

45.09

+0.98 (+2.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-09 2024-12-09/amc
Earnings (Next)N/A N/A
Inst Owners78.73%
Inst Owner Change0%
Ins Owners1.03%
Ins Owner Change-17.84%
Market Cap4.67B
Analysts83.2
Price Target51.13 (13.4%)
Short Float %6.17%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)448.89%
Min EPS beat(2)374.28%
Max EPS beat(2)523.5%
EPS beat(4)4
Avg EPS beat(4)241.85%
Min EPS beat(4)17.82%
Max EPS beat(4)523.5%
EPS beat(8)8
Avg EPS beat(8)144.84%
EPS beat(12)12
Avg EPS beat(12)102.81%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.77%
Min Revenue beat(2)0.59%
Max Revenue beat(2)0.95%
Revenue beat(4)4
Avg Revenue beat(4)1.31%
Min Revenue beat(4)0.59%
Max Revenue beat(4)2.83%
Revenue beat(8)8
Avg Revenue beat(8)1.83%
Revenue beat(12)12
Avg Revenue beat(12)2.49%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.09%
PT rev (3m)-15.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.35%
EPS NY rev (1m)0%
EPS NY rev (3m)263.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE 2254.5
Fwd PE 152.35
P/S 8.27
P/FCF 5254.41
P/OCF 199.24
P/B 10.19
P/tB 10.94
EV/EBITDA N/A
EPS(TTM)0.02
EY0.04%
EPS(NY)0.3
Fwd EY0.66%
FCF(TTM)0.01
FCFY0.02%
OCF(TTM)0.23
OCFY0.5%
SpS5.45
BVpS4.43
TBVpS4.12
PEG (NY)15.72
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.64%
ROE -25.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.64%
FCFM 0.16%
ROA(3y)-15.71%
ROA(5y)-17.29%
ROE(3y)-25.19%
ROE(5y)-32.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.56%
GM growth 5YN/A
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 243.59%
Cap/Sales 3.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z 6.93
F-Score6
WACC11.19%
ROIC/WACCN/A
Cap/Depr(3y)237.11%
Cap/Depr(5y)275.44%
Cap/Sales(3y)3.12%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y143.4%
EPS Next 2Y77.15%
EPS Next 3Y61.01%
EPS Next 5YN/A
Revenue 1Y (TTM)28.3%
Revenue growth 3Y46.45%
Revenue growth 5YN/A
Sales Q2Q%22.66%
Revenue Next Year26.43%
Revenue Next 2Y21.6%
Revenue Next 3Y20.14%
Revenue Next 5YN/A
EBIT growth 1Y11.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.3%
EBIT Next 3Y52.7%
EBIT Next 5YN/A
FCF growth 1Y101.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.99%
OCF growth 3YN/A
OCF growth 5YN/A